Table 5. Correlation of FST in KDIGO stage 1 and their progression during follow-up.
KDIGO: Kidney disease improving global outcomes, FST: Furosemide stress test.
| KDIGO Stage on Day 1 | FST | Non-progressor | Progressor | Total n(%) | |
| KDIGO 1 n(%) | KDIGO 2 n(%) | KDIGO 3 n(%) | |||
| Stage 1 | Responder | 20(40) | 6(12) | 24(48) | 50(32.46) |
| Non-responder | 2(13.3) | 3(20) | 10(66.67) | 15(9.74) | |
| P-value | <0.001 | 0.689 | 0.011 | ||